Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$80.64

-0.81 (-0.99%)

, RHHBY

Roche

$0.00

(0.00%)

08:48
03/19/19
03/19
08:48
03/19/19
08:48
Hot Stocks
AbbVie: FDA puts partial clinical hold on venetoclax program »

AbbVie (ABBV) announced…

ABBV

AbbVie

$80.64

-0.81 (-0.99%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 17

    Apr

  • 18

    May

  • 19

    Aug

  • 04

    Nov

AFMD

Affimed N.V.

$3.92

-0.08 (-2.00%)

, RHHBY

Roche

$0.00

(0.00%)

06:18
03/19/19
03/19
06:18
03/19/19
06:18
Hot Stocks
Affimed to receive milestone payment under collaboration with Genentech »

Affimed (AFMD) announced…

AFMD

Affimed N.V.

$3.92

-0.08 (-2.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

RHHBY

Roche

$0.00

(0.00%)

05:16
03/19/19
03/19
05:16
03/19/19
05:16
Hot Stocks
Roche announces FDA approval of Tecentriq with chemotherapy for lung cancer »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

Monday
ARWR

Arrowhead

$18.61

0.05 (0.27%)

, EIGR

Eiger BioPharmaceuticals

$13.18

-0.13 (-0.98%)

09:18
03/18/19
03/18
09:18
03/18/19
09:18
Conference/Events
Jefferies to hold a summit »

HBV Investor Summit will…

ARWR

Arrowhead

$18.61

0.05 (0.27%)

EIGR

Eiger BioPharmaceuticals

$13.18

-0.13 (-0.98%)

ABUS

Arbutus Biopharma

$3.83

0.08 (2.13%)

SBPH

Spring Bank Pharmaceuticals

$10.60

0.15 (1.44%)

ASMB

Assembly Biosciences

$20.23

0.0103 (0.05%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 18

    Mar

  • 04

    Apr

  • 04

    Apr

  • 17

    Apr

  • 19

    Aug

  • 04

    Nov

Friday
RHHBY

Roche

$0.00

(0.00%)

05:48
03/15/19
03/15
05:48
03/15/19
05:48
Hot Stocks
Roche announces EC approval of MabThera »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 04

    Apr

  • 19

    Aug

  • 04

    Nov

Thursday
INFI

Infinity Pharmaceuticals

$1.54

0.1 (6.94%)

, RHHBY

Roche

$0.00

(0.00%)

07:06
03/14/19
03/14
07:06
03/14/19
07:06
Hot Stocks
Infinity Pharmaceuticals to initiate MARIO-3 »

Infinity Pharmaceuticals…

INFI

Infinity Pharmaceuticals

$1.54

0.1 (6.94%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 14

    Mar

  • 18

    Mar

  • 20

    Mar

  • 04

    Apr

  • 19

    Aug

  • 04

    Nov

RHHBY

Roche

$0.00

(0.00%)

05:36
03/14/19
03/14
05:36
03/14/19
05:36
Hot Stocks
Roche announces EC approval of Hemlibra »

Roche announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 18

    Mar

  • 04

    Apr

  • 19

    Aug

  • 04

    Nov

CLLS

Cellectis

$18.86

0.1 (0.53%)

, ABBV

AbbVie

$78.91

0.18 (0.23%)

04:55
03/14/19
03/14
04:55
03/14/19
04:55
Conference/Events
Barclays to hold a conference »

Global Healthcare…

CLLS

Cellectis

$18.86

0.1 (0.53%)

ABBV

AbbVie

$78.91

0.18 (0.23%)

ZYME

Zymeworks

$16.84

0.26 (1.57%)

BTAI

BioXcel Therapeutics

$9.31

0.01 (0.11%)

DGX

Quest Diagnostics

$88.32

1.51 (1.74%)

QGEN

Qiagen

$39.75

0.41 (1.04%)

MMSI

Merit Medical

$60.44

1.01 (1.70%)

BRKR

Bruker

$38.35

0.41 (1.08%)

RHHBY

Roche

$0.00

(0.00%)

MYOV

Myovant Sciences

$22.13

0.01 (0.05%)

GRTS

Gritstone Oncology

$10.67

0.14 (1.33%)

LOGC

LogicBio Therapeutics

$9.83

-0.16 (-1.60%)

ANGO

AngioDynamics

$21.65

-0.02 (-0.09%)

HRC

Hill-Rom

$104.50

-0.54 (-0.51%)

OMI

Owens & Minor

$4.80

0.08 (1.69%)

EIDX

Eidos Therapeutics

$18.85

-0.5 (-2.58%)

BCRX

BioCryst

$8.20

-0.135 (-1.62%)

CNC

Centene

$59.96

1.67 (2.87%)

HUM

Humana

$283.10

8.79 (3.20%)

GEN

Genesis Healthcare

$1.40

(0.00%)

HCA

HCA Healthcare

$130.81

1.92 (1.49%)

INCY

Incyte

$85.00

0.13 (0.15%)

EXAS

Exact Sciences

$94.80

1.29 (1.38%)

QURE

uniQure

$65.00

-0.46 (-0.70%)

TECH

Bio-Techne

$194.87

1.72 (0.89%)

NTEC

Intec Pharma

$7.22

0.37 (5.40%)

PODD

Insulet

$95.70

-0.2 (-0.21%)

EXEL

Exelixis

$24.72

1.14 (4.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 15

    Mar

  • 17

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 19

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    Mar

  • 02

    Apr

  • 04

    Apr

  • 04

    Apr

  • 10

    Apr

  • 18

    May

  • 24

    May

  • 28

    May

  • 19

    Aug

  • 04

    Nov

Over a week ago
CLLS

Cellectis

$18.76

0.41 (2.23%)

, ABBV

AbbVie

$78.73

0.655 (0.84%)

04:55
03/13/19
03/13
04:55
03/13/19
04:55
Conference/Events
Barclays to hold a conference »

Global Healthcare…

CLLS

Cellectis

$18.76

0.41 (2.23%)

ABBV

AbbVie

$78.73

0.655 (0.84%)

ZYME

Zymeworks

$16.58

-0.12 (-0.72%)

BTAI

BioXcel Therapeutics

$9.30

0.53 (6.04%)

DGX

Quest Diagnostics

$86.81

1.39 (1.63%)

QGEN

Qiagen

$39.34

0.01 (0.03%)

MMSI

Merit Medical

$59.43

1.05 (1.80%)

BRKR

Bruker

$37.94

-0.19 (-0.50%)

RHHBY

Roche

$0.00

(0.00%)

MYOV

Myovant Sciences

$22.12

-0.37 (-1.65%)

GRTS

Gritstone Oncology

$10.53

-0.15 (-1.40%)

LOGC

LogicBio Therapeutics

$9.99

-0.25 (-2.44%)

ANGO

AngioDynamics

$21.67

0.14 (0.65%)

HRC

Hill-Rom

$105.04

0.55 (0.53%)

OMI

Owens & Minor

$4.72

-0.04 (-0.84%)

EIDX

Eidos Therapeutics

$19.35

2.29 (13.42%)

BCRX

BioCryst

$8.33

0.02 (0.24%)

CNC

Centene

$58.29

0.89 (1.55%)

HUM

Humana

$274.31

1.07 (0.39%)

GEN

Genesis Healthcare

$1.40

(0.00%)

HCA

HCA Healthcare

$128.89

3.01 (2.39%)

INCY

Incyte

$84.87

0.69 (0.82%)

EXAS

Exact Sciences

$93.51

2.63 (2.89%)

QURE

uniQure

$65.46

0.12 (0.18%)

TECH

Bio-Techne

$193.15

1.26 (0.66%)

NTEC

Intec Pharma

$6.85

0.17 (2.54%)

PODD

Insulet

$95.90

1.9 (2.02%)

EXEL

Exelixis

$23.58

0.04 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 15

    Mar

  • 17

    Mar

  • 18

    Mar

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 19

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    Mar

  • 02

    Apr

  • 04

    Apr

  • 04

    Apr

  • 10

    Apr

  • 18

    May

  • 24

    May

  • 28

    May

  • 19

    Aug

  • 04

    Nov

RHHBY

Roche

$0.00

(0.00%)

, CELG

Celgene

$85.60

0.34 (0.40%)

16:36
03/12/19
03/12
16:36
03/12/19
16:36
Hot Stocks
Celgene says Tecentriq / Abraxane combo gets accelerated FDA approval for TNBC »

Celgene (CELG) announced…

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$85.60

0.34 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 12

    Mar

  • 12

    Mar

  • 18

    Mar

  • 04

    Apr

  • 12

    Apr

  • 18

    May

  • 28

    May

  • 27

    Jun

  • 19

    Aug

  • 03

    Sep

  • 04

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.